Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 54.69%-44.6K | -128.31%-231.83K | 412.29%20.85K | -25.40%-74.47K | -108.41%-79.77K | -32.33%-98.44K | 1,206.42%818.9K | 100.33%4.07K | -104.96%-59.38K | 258.75%948.61K |
| Net income from continuing operations | 69.59%-10.05K | 249.69%420.81K | 341.05%585.86K | -527.72%-70.8K | -69.23%-61.2K | -452.73%-33.04K | 98.42%-281.12K | 92.53%-243.05K | 99.85%-11.28K | 99.52%-36.17K |
| Operating gains losses | ---39.21K | ---466.39K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Remuneration paid in stock | ---- | --0 | ---- | ---- | ---- | ---- | --139.21K | ---- | ---- | ---- |
| Other non cashItems | ---- | ---- | ---- | --10 | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 107.12%4.66K | -119.38%-186.25K | -189.51%-96.58K | 92.36%-3.68K | -102.09%-20.59K | 21.92%-65.4K | 6.09%960.81K | 135.35%107.9K | -109.49%-48.1K | 1,010.88%984.77K |
| -Change in receivables | 121.99%8.14K | -117.40%-170.25K | -260.79%-105.66K | 15.28%-31.62K | -99.60%4.07K | 50.62%-37.04K | 387.83%978.47K | -73.56%65.71K | 31.05%-37.32K | 377.74%1.03M |
| -Change in prepaid assets | 129.19%3.42K | -73.42%-6.41K | -366.07%-16.11K | 253.31%18.32K | -191.40%-10.12K | 116.80%1.49K | -100.36%-3.7K | -71.10%6.05K | -102.11%-11.95K | -85.42%11.07K |
| -Change in payables and accrued expense | 76.87%-6.9K | 31.35%-9.58K | -30.31%25.18K | 670.83%9.62K | 71.75%-14.54K | -24,972.50%-29.85K | 95.81%-13.96K | 106.29%36.14K | 120.72%1.25K | -127.81%-51.47K |
| -Change in other current assets | ---- | ---- | ---- | ---- | ---- | ---24.08K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 54.69%-44.6K | -128.31%-231.83K | 412.29%20.85K | -25.40%-74.47K | -108.41%-79.77K | -32.33%-98.44K | 1,206.42%818.9K | 100.33%4.07K | -104.96%-59.38K | 3,055.19%948.61K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 679.42%139.5K | 107.08%61.35K | -49.69%62.02K | 284.36%151.2K | -127.8K | -24.08K | -94.35%-866.94K | -70.07%123.29K | 75.03%-82.02K | |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | 679.42%139.5K | 107.08%61.35K | -49.69%62.02K | 284.36%151.2K | ---127.8K | ---24.08K | 61.30%-866.94K | 105.50%123.29K | ---82.02K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 679.42%139.5K | 107.08%61.35K | -49.69%62.02K | 284.36%151.2K | ---127.8K | ---24.08K | -94.35%-866.94K | -70.07%123.29K | 75.03%-82.02K | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Cash from discontinued financing activities | ||||||||||
| Net cash flow | ||||||||||
| Beginning cash position | -59.56%115.78K | 47.33%286.26K | -75.61%28.03K | -39.44%117.75K | 51.58%190.66K | 47.33%286.26K | -62.11%194.3K | -54.32%114.94K | 968.44%194.43K | -56.53%125.78K |
| Current changes in cash | 177.45%94.89K | -254.94%-170.49K | -34.93%82.87K | 154.27%76.74K | -613.77%-207.57K | -64.69%-122.52K | 90.76%-48.03K | 115.62%127.36K | -116.27%-141.4K | 111.74%40.4K |
| Effect of exchange rate changes | --0 | --0 | -88.92%4.87K | -368.90%-166.45K | 376.62%134.67K | 358.61%26.91K | -30.56%139.99K | -94.01%43.97K | 109.91%61.9K | -67.23%28.26K |
| End cash Position | 10.50%210.67K | -59.56%115.78K | -59.56%115.78K | -75.61%28.03K | -39.44%117.75K | 51.58%190.66K | 47.33%286.26K | 47.33%286.26K | -54.32%114.94K | 968.44%194.43K |
| Free cash from | 54.69%-44.6K | -128.31%-231.83K | 412.29%20.85K | -25.40%-74.47K | -108.41%-79.77K | -32.33%-98.44K | 1,206.42%818.9K | 100.33%4.07K | -104.96%-59.38K | 3,055.19%948.61K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.